rxstat › Shortages › Mycophenolic Acid

Mycophenolic Acid shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Mycophenolic Acid has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 5
Reports on file
14

Reports by product

Resolved
APO-MYCOPHENOLIC ACID
360MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02372746 · ended Jan 2, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP MYCOPHENOLIC ACID
360MG · TABLET (ENTERIC-COATED) TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02518511 · ended Mar 17, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-MYCOPHENOLIC ACID
360MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02372746 · ended Jun 13, 2024 · Disruption of the manufacture of the drug.
Resolved
MAR-MYCOPHENOLIC ACID
180MG · TABLET (ENTERIC-COATED) · MARCAN PHARMACEUTICALS INC
DIN 02511673 · ended Jan 16, 2024 · Demand increase for the drug.
Resolved
APO-MYCOPHENOLIC ACID
180MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02372738 · ended Jan 12, 2023 · Disruption of the manufacture of the drug.
Resolved
MYCOPHENOLIC ACID
180MG · TABLET (DELAYED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02518538 · ended Jan 5, 2023 · Demand increase for the drug.
Resolved
APO-MYCOPHENOLIC ACID
360MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02372746 · ended Dec 7, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-MYCOPHENOLIC ACID
360MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02372746 · ended Jul 23, 2021 · Disruption of the manufacture of the drug.
Resolved
APO-MYCOPHENOLIC ACID
180MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02372738 · ended Jul 23, 2021 · Disruption of the manufacture of the drug.
Resolved
APO-MYCOPHENOLIC ACID
360MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02372746 · ended Apr 9, 2021 · Disruption of the manufacture of the drug.
Resolved
APO-MYCOPHENOLIC ACID
180MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02372738 · ended Jan 22, 2021 · Disruption of the manufacture of the drug.
Resolved
APO-MYCOPHENOLIC ACID
360MG · TABLET (ENTERIC-COATED) · APOTEX INC
DIN 02372746 · ended Dec 28, 2020 · Disruption of the manufacture of the drug.

Showing 12 of 14 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Mycophenolic Acid. Health Canada has 14 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Mycophenolic Acid is classified under “IMMUNOSUPPRESSANTS” (ATC L04AA).

Recent changes

Common questions

When will Mycophenolic Acid be back in stock in Canada?

Mycophenolic Acid has no active shortage; supply is normal per Health Canada reports.

Why is Mycophenolic Acid in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (immunosuppressants)

Widespread shortageApremilast2 of 3 reported products affectedPartial shortageAdalimumab1 of 7 reported products affectedPartial shortageApremilast Apremilast Apremilast1 of 1 reported products affected · est. return Aug 28, 2026Partial shortageBasiliximab1 of 1 reported products affectedPartial shortageCyclosporine1 of 8 reported products affected · est. return Jul 30, 2027Partial shortageFingolimod3 of 8 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.